Press Release: Santhera and Cold Spring Harbor -2-


Werte in diesem Artikel

subscribe for or purchase any securities of Santhera Pharmaceuticals

Holding AG. This publication may contain certain forward-looking

Werbung

statements concerning the Company and its business. Such statements

involve certain risks, uncertainties and other factors which could cause

the actual results, financial condition, performance or achievements of

the Company to be materially different from those expressed or implied

by such statements. Readers should therefore not place undue reliance on

these statements, particularly not in connection with any contract or

Werbung

investment decision. The Company disclaims any obligation to update

these forward-looking statements.

# # #

Attachment

-- 2020 04 27_CSHL_lono_covid_e_final

https://ml-eu.globenewswire.com/Resource/Download/d71fd396-9234-420d-b5a0-f851478fe678

(END) Dow Jones Newswires

April 27, 2020 01:00 ET (05:00 GMT)

Aktuelle Santhera Pharmaceuticals Aktie News

Werbung

Santhera Pharmaceuticals Analysen

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Santhera Pharmaceuticals nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
DatumRatingAnalyst
28.02.11 Santhera Pharmaceuticals hold Vontobel Research
18.02.11 Santhera Pharmaceuticals hold Vontobel Research
08.02.11 Santhera Pharmaceuticals hold Vontobel Research
25.10.10 Santhera Pharmaceuticals hold Vontobel Research
14.10.10 Santhera Pharmaceuticals hold Vontobel Research